Our commitment
Provide patients with quality medicines
Biogaran is commited to providing patients with affordable bioequivalent quality medicines that comply with the most stringent European standards.
Put quality at the center of our manufacturing process
Since its creation, the main goal of Biogaran has been to provide patients with quality generic drugs that they will be able to take safely.
Biogaran generic drugs are bioequivalent to the originator’s drug: they are made of the same active ingredients and have the same therapeutic efficacy.
Moreover, 89% of our finished products are manufactured in Europe, nearly 50% of them in France¹, and we have 44 partner production sites² in France.
Click here to discover the available drugs in your country
1. Internal data - Finished product manufacturing - November 20242. Internal data - Production sites - November 2024
Your health is our main concern
Since Biogaran was founded in 1996, our laboratory’s objective has always been to reinvent itself in order to meet patients’ needs and provide them with the widest possible range of therapeutic solutions.
This is why, for more than 25 years now, Biogaran has been working to develop as many generic medicines as possible. In this way, whatever the disease, Biogaran is by your side.
Today, this approach allows Biogaran to have a very large portfolio that can treat the majority of pathologies.
The same seriousness, rigor and quality are applied to the development of each medicine. Because patients’ health is at the heart of our concerns.